Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics

• Published in: Drug development and industrial pharmacy Vol. 46; no. 2; p. 309
• Main Authors: Suárez-González, Javier, Santoveña-Estévez, Ana, Soriano, Mabel, Fariña, José B
• Format: Journal Article
• Language: English
• Published: England 01.02.2020
• Subjects: treatment; Tuberculosis; dispersible tablet; children; direct compression; pediatric
• ISSN: 1520-5762
• DOI: 10.1080/03639045.2020.1717516

Develop a child-friendly Fixed Dose Combination (FDC) water-dispersible tablet for Tuberculosis (TB) treatment, with 50, 150, and 75 mg of isoniazid, pyrazinamide and rifampicin respectively. This new formulation must contain the lowest number of excipients accepted for pediatrics and fulfill all the pharmacopeia requirements. At present, there is no adequate market dosage form available for children. There is, however, one in a prequalification phase by the World Health Organization but its composition contains excipients which may not be suitable for pediatrics. Therefore, this new formulation would cover this therapeutic gap. A factorial design, based on three quantitative factors (compression force and concentration of AcDiSol and Explosol ) at three levels each, was performed to elucidate their influence over disintegration time and friability. In addition, the influence of the press speed on disintegration time, friability, tensile strength, fineness of dispersion and content uniformity over the target tablet was tested. A stability test was done following ICH guideline for accelerated conditions. Tablets developed with 9% w/w of Explosol and a compression force of 16 kN disintegrated in less than 3 min and showed a friability below 1% when 15-mm punches were used. The tableting process could be done up to 25 and 50 cycles/minute ensuring good quality attributes when 15 and 12-mm punches were used, respectively. All APIs remained inside the limit of ± 5% of drug content till 6 months of storage. A high-quality child-friendly FDC water-dispersible tablet was developed improving the treatment of TB in pediatric.